Clinical UpdatesDrug News

Britain’s healthcare cost agency plans to end controversial restrictions on Alzheimer’s drugs in a policy U-turn that could give hundreds… »   

Influenza pandemics often come in multiple waves. As the one wave subsides, public health officials have to decide whether… »   

Researchers have combined vaccines against smallpox and anthrax into one vaccine that could protect against both germs in a biological… »   

Health insurer Humana Inc and Walmart will team up to offer a U.S. Medicare prescription drug coverage plan next year… »   

Fisher-Price, a unit of toymaker Mattel Inc, on Thursday said it will recall about 10 million toys and other items… »   

MIT researchers and collaborators from Tufts University have now engineered E. coli bacteria to produce large quantities of a… »   

Johnson & Johnson disappointed consumers in recalling millions of bottles of popular children’s medicines, but products should be back… »   

Abbott Laboratories posted a list of lot numbers on Thursday for the millions of recalled containers of its Similac powdered… »   

Amgen Inc and Johnson & Johnson are recalling their Epogen and Procrit anemia treatments because of the potential for barely… »   

U.S. health regulators knew that Johnson & Johnson’s McNeil unit was using a contractor to buy back potentially faulty batches… »   

The FDA (Food and Drug Administration, USA) has approved Medronic’s Integrity Coronary Stent System, based on an advanced biomedical engineering… »   

An experimental diabetes drug from AstraZeneca and Bristol-Myers Squibb met its primary targets in a late-stage clinical trial, achieving significant… »   

The company that makes the antidepressant Celexa has agreed to pay more than $313 million to settle criminal charges and… »   

A new process to review medical products at the U.S. Food and Drug Administration in tandem with the nation’s Medicare… »   

Vaccine maker Sanofi Aventis asked U.S. regulators on Monday to approve a new flu vaccine that uses a short, thin… »